IGFALS: Key Protein Interaction in IGF-1 Signaling Pathway (G3483)

Target Name: IGFALS

NCBI ID: G3483

IGFALS

Other Name(s): Insulin-like growth factor binding protein complex acid labile chain | IGFALS variant 2 | Insulin-like growth factor-binding protein complex acid labile subunit (isoform 2) | insulin like growth factor binding protein acid labile subunit | Insulin like growth factor binding protein acid labile subunit, transcript variant 2 | Insulin-like growth factor-binding protein complex acid labile subunit (isoform 1) | ALS_HUMAN | Insulin-like growth factor-binding protein complex acid labile subunit | ACLSD | IGFALS variant 1 | Insulin-like growth factor-binding protein complex acid labile chain [Precursor] | insulin-like growth factor binding protein complex acid labile chain | ALS | Insulin like growth factor binding protein acid labile subunit, transcript variant 1

IGFALS: Key Protein Interaction in IGF-1 Signaling Pathway

The insulin-like growth factor (IGF) signaling pathway is a critical signaling pathway that regulates cellular growth, differentiation, and survival. The IGF pathway is a complex signaling pathway that involves the interactions of multiple proteins, including IGF-1, IGF-2, IGF-3, IGF-5, and IGF-6. One of the key proteins that interacts with IGF-1 and IGF-2 is the insulin-like growth factor binding protein complex (IGFALS). IGFALS is a protein that is composed of four distinct chains, including an acid labile chain (ALC), a 尾-sheet chain (BSC), a transmembrane region (TMR), and a C-terminus. The functions of these chains are not yet fully understood, but they are believed to play important roles in the regulation of cellular processes, including cell growth, differentiation, and survival.

The IGF pathway is a critical signaling pathway that regulates cellular growth, differentiation, and survival. The IGF pathway is a complex signaling pathway that involves the interactions of multiple proteins, including IGF-1, IGF-2, IGF-3, IGF-5, and IGF-6. One of the key proteins that interacts with IGF-1 and IGF-2 is the insulin-like growth factor binding protein complex (IGFALS).

IGFALS is a protein that is composed of four distinct chains, including an acid labile chain (ALC), a 尾-sheet chain (BSC), a transmembrane region (TMR), and a C-terminus. The functions of these chains are not yet fully understood, but they are believed to play important roles in the regulation of cellular processes, including cell growth, differentiation, and survival.

The IGF-1 signaling pathway is a complex process that involves the interactions of multiple proteins, including the insulin-like growth factor binding protein complex (IGFALS). IGFALS is a protein that is composed of four distinct chains, including an acid labile chain (ALC), a 尾-sheet chain (BSC), a transmembrane region (TMR), and a C-terminus. The functions of these chains are not yet fully understood, but they are believed to play important roles in the regulation of cellular processes, including cell growth, differentiation, and survival.

IGFALS is a key protein that interacts with IGF-1 and IGF-2. It is thought to play a role in the regulation of cellular processes, including cell growth, differentiation, and survival. The IGF-1 signaling pathway is a complex process that involves the interactions of multiple proteins, including IGFAL

Protein Name: Insulin Like Growth Factor Binding Protein Acid Labile Subunit

Functions: Involved in protein-protein interactions that result in protein complexes, receptor-ligand binding or cell adhesion

The "IGFALS Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about IGFALS comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets